Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 108

1.

Fibrolamellar hepatocellular carcinoma in the USA, 2000-2010: A detailed report on frequency, treatment and outcome based on the Surveillance, Epidemiology, and End Results database.

Eggert T, McGlynn KA, Duffy A, Manns MP, Greten TF, Altekruse SF.

United European Gastroenterol J. 2013 Oct;1(5):351-7. doi: 10.1177/2050640613501507.

2.
3.

Hepatocellular carcinoma confirmation, treatment, and survival in surveillance, epidemiology, and end results registries, 1992-2008.

Altekruse SF, McGlynn KA, Dickie LA, Kleiner DE.

Hepatology. 2012 Feb;55(2):476-82. doi: 10.1002/hep.24710.

4.

Clinicopathological features and surgical outcome of patients with fibrolamellar hepatocellular carcinoma (experience with 22 patients over a 15-year period).

Wahab MA, El Hanafy E, El Nakeeb A, Ali MA.

World J Gastrointest Surg. 2017 Feb 27;9(2):61-67. doi: 10.4240/wjgs.v9.i2.61.

6.

Fibrolamellar variant of hepatocellular carcinoma does not have a better survival than conventional hepatocellular carcinoma--results and treatment recommendations from the Childhood Liver Tumour Strategy Group (SIOPEL) experience.

Weeda VB, Murawski M, McCabe AJ, Maibach R, Brugières L, Roebuck D, Fabre M, Zimmermann A, Otte JB, Sullivan M, Perilongo G, Childs M, Brock P, Zsíros J, Plaschkes J, Czauderna P, Aronson DC.

Eur J Cancer. 2013 Aug;49(12):2698-704. doi: 10.1016/j.ejca.2013.04.012. Epub 2013 May 15.

7.

Fibrolamellar hepatocellular carcinoma in a Japanese man: report of a case.

Yoshimi F, Asato Y, Amemiya R, Itabashi M, Nakamura K.

Surg Today. 2002;32(2):174-9. Review.

PMID:
11998950
8.

Racial disparities in treatment and survival of patients with hepatocellular carcinoma in the United States.

Xu L, Kim Y, Spolverato G, Gani F, Pawlik TM.

Hepatobiliary Surg Nutr. 2016 Feb;5(1):43-52. doi: 10.3978/j.issn.2304-3881.2015.08.05.

9.

Treatment and prognosis of patients with fibrolamellar hepatocellular carcinoma: a national perspective.

Mayo SC, Mavros MN, Nathan H, Cosgrove D, Herman JM, Kamel I, Anders RA, Pawlik TM.

J Am Coll Surg. 2014 Feb;218(2):196-205. doi: 10.1016/j.jamcollsurg.2013.10.011. Epub 2013 Oct 24.

10.

Clinical and pathological evaluation of fibrolamellar hepatocellular carcinoma: a single center study of 21 cases.

Chagas AL, Kikuchi L, Herman P, Alencar RS, Tani CM, Diniz MA, Pugliese V, Rocha Mde S, D'Albuquerque LA, Carrilho FJ, Alves VA.

Clinics (Sao Paulo). 2015 Mar;70(3):207-13. doi: 10.6061/clinics/2015(03)10. Epub 2015 Mar 1.

11.
12.

Earlier presentation and application of curative treatments in hepatocellular carcinoma.

Ulahannan SV, Duffy AG, McNeel TS, Kish JK, Dickie LA, Rahma OE, McGlynn KA, Greten TF, Altekruse SF.

Hepatology. 2014 Nov;60(5):1637-44. doi: 10.1002/hep.27288. Epub 2014 Sep 29.

13.

A review of 218 pediatric cases of hepatocellular carcinoma.

Allan BJ, Wang B, Davis JS, Parikh PP, Perez EA, Neville HL, Sola JE.

J Pediatr Surg. 2014 Jan;49(1):166-71; discussion 171. doi: 10.1016/j.jpedsurg.2013.09.050. Epub 2013 Oct 5. Review.

PMID:
24439603
14.

Hepatocellular carcinoma incidence, mortality, and survival trends in the United States from 1975 to 2005.

Altekruse SF, McGlynn KA, Reichman ME.

J Clin Oncol. 2009 Mar 20;27(9):1485-91. doi: 10.1200/JCO.2008.20.7753. Epub 2009 Feb 17.

15.

Race/Ethnicity-specific Disparities in Hepatocellular Carcinoma Stage at Diagnosis and its Impact on Receipt of Curative Therapies.

Ha J, Yan M, Aguilar M, Tana M, Liu B, Frenette CT, Bhuket T, Wong RJ.

J Clin Gastroenterol. 2016 May-Jun;50(5):423-30. doi: 10.1097/MCG.0000000000000448.

PMID:
26583267
16.

Natural history and treatment trends in hepatocellular carcinoma subtypes: Insights from a national cancer registry.

Jernigan PL, Wima K, Hanseman DJ, Hoehn RS, Ahmad SA, Shah SA, Abbott DE.

J Surg Oncol. 2015 Dec;112(8):872-6. doi: 10.1002/jso.24083. Epub 2015 Nov 25.

PMID:
26603598
17.
18.

Improved survival of patients with hepatocellular carcinoma and disparities by age, race, and socioeconomic status by decade, 1983-2012.

Wang S, Sun H, Xie Z, Li J, Hong G, Li D, Mallampati S, Zhou X, Zhou C, Zhang H, Cheng Z, Shan H, Ma H.

Oncotarget. 2016 Sep 13;7(37):59820-59833. doi: 10.18632/oncotarget.10930.

19.

Childhood cancer among Alaska Natives.

Lanier AP, Holck P, Ehrsam Day G, Key C.

Pediatrics. 2003 Nov;112(5):e396.

PMID:
14595083
20.

Fibrolamellar hepatocellular carcinoma coexistent with a hepatocellular carcinoma of common type: report of a case.

Okada K, Kim YI, Nakashima K, Tada I, Yoshida T, Kobayashi M, Yokoyama S.

Surg Today. 1993;23(7):626-31. Review.

PMID:
7690275

Supplemental Content

Support Center